Showing results (21-30 of 155) with videos related to
Sort By:
Pageof 16
Blood Advances|September 27, 2021
Follicular lymphoma and macrophages: impact of approved and novel therapiesSushanth Gouni, Mario L Marques-Piubelli, Paolo StratiLeukemia & Lymphoma|June 30, 2025
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse eventsEnrico Derenzini, Adam Gibb, Michał Kwiatek, et al.JCO Oncology Practice|July 5, 2023
Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical ReviewPaolo Strati, Tara Gregory, Navneet S Majhail, et al.Bone Marrow Transplantation|August 10, 2023
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioningShanze Arshad, Xi Fang, Kwang W Ahn, et al.Blood Advances|December 24, 2019
Venetoclax for AML: changing the treatment paradigmDaniel A Pollyea, Maria Amaya, Paolo Strati, et al.The Lancet. Haematology|January 18, 2021
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?Carlota Gudiol, Russell E Lewis, Paolo Strati, et al.Clinical Lymphoma, Myeloma & Leukemia|November 6, 2012
Long-term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anti-CD52 antibodyPaolo Strati, Jorge Cortes, Stefan Faderl, et al.Leukemia Research|March 22, 2017
Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevancePaolo Strati, Lucia Masarova, Prithviraj Bose, et al.Diagnostic Microbiology and Infectious Disease|March 5, 2025
Whipple's disease in a patient with follicular lymphomaPatrycja Ashley, Paolo Strati, Mehran Taherian, et al.Blood|February 5, 2016
Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysisSameer A Parikh, Paolo Strati, Mazie Tsang, et al.Pageof 16